Hormones

Testosterone Cypionate

Evidence: strong_human

Mechanism of Action

Testosterone cypionate is an esterified prodrug of testosterone that undergoes hydrolysis in vivo to release free testosterone. It binds the androgen receptor (AR), activating genomic pathways via AR nuclear translocation and transcription of anabolic genes including IGF-1, satellite cell proliferation, and nitrogen retention. Additionally, testosterone exerts non-genomic effects through membrane-associated AR signaling, modulating calcium influx and MAPK/ERK pathways. Aromatization to estradiol via CYP19A1 (aromatase) maintains bone density and lipid profiles.

Dosing Protocol

Standard: Research indicates 100-200 mg administered via intramuscular or subcutaneous injection every 7-14 days for testosterone replacement therapy.

Maintenance: Research indicates 100-150 mg weekly (or 50-75 mg twice weekly for more stable serum levels) titrated to trough total testosterone of 500-900 ng/dL.

Administration: intramuscularsubcutaneous

Timing: Inject on a consistent schedule. Twice-weekly dosing (e.g., Monday/Thursday) reduces peak-trough fluctuations. Morning injection preferred for alignment with circadian testosterone rhythm.

Duration: Ongoing for TRT. If discontinuing, taper and implement PCT protocol. Testicular function suppression occurs within 2-4 weeks of initiation.

Notes

Testosterone cypionate has an 8-day half-life following IM injection. Required bloodwork monitoring: Total testosterone (trough), free testosterone, estradiol (sensitive assay), CBC with hematocrit (every 3-6 months — hold if hematocrit >54%), PSA (baseline + annual if >40), comprehensive metabolic panel, lipid panel. Therapeutic blood donation recommended if hematocrit exceeds 52%. The Endocrine Society 2018 guidelines recommend against TRT in men planning fertility without concomitant hCG. Medical supervision required.

Stacking

  • hCG (fertility preservation)
  • Anastrozole (estrogen management)
  • DHEA
  • Nandrolone (joint support)

Interactions

  • Anticoagulants (Warfarin) [HIGH] — Testosterone increases erythropoiesis and may potentiate anticoagulant effects; monitor INR closely.
  • Insulin / Oral hypoglycemics [MEDIUM] — Testosterone improves insulin sensitivity; may require dose adjustment of diabetes medications.
  • Corticosteroids [MEDIUM] — Concurrent use may increase fluid retention; monitor for edema.
  • 5-alpha reductase inhibitors (Finasteride) [LOW] — Reduces conversion to DHT; may blunt androgenic effects on hair, skin, and prostate.

Contraindications

  • Prostate cancer or elevated PSA without urological clearance
  • Male breast cancer
  • Polycythemia (hematocrit >54%)
  • Untreated severe obstructive sleep apnea
  • Uncontrolled heart failure
  • Desire for near-term fertility (without hCG adjunct)
  • Women who are pregnant or may become pregnant

Side Effects

  • Polycythemia / elevated hematocrit
  • Acne and oily skin
  • Testicular atrophy (without hCG)
  • Gynecomastia (from aromatization)
  • Mood changes and irritability
  • Fluid retention
  • Elevated liver enzymes (rare with injectable)
  • Sleep apnea exacerbation

Key Papers

  • 10.1210/jc.2018-01307
  • 10.1111/cen.13840
  • 10.1210/clinem/dgaa120

Source Quality

FDA-approved pharmaceutical product (Depo-Testosterone). Available from compounding pharmacies (200 mg/mL in grape seed or cottonseed oil). Ensure USP-grade with prescription.

Disclaimer: This information is for educational purposes only and is not medical advice. BioAccelera Labs does not diagnose, treat, or prescribe. Consult a licensed healthcare provider before using any compound.

Should Testosterone Cypionate Be in Your Stack?

Take the free assessment and get personalized recommendations based on your biology and goals.

Get Your Free Protocolor take the assessment →
← Browse All 231 Compounds